Category Innovation/ R&D

Data From Clinical Trials Identify Gaps In Health R&D

Lower-income countries receive much less attention in terms of clinical trial research, according to a study published in this month’s World Health Organization (WHO) Bulletin. The study also underscored the value and importance the WHO International Clinical Trials Registry Platform (ICTRP) provides as a resource for evaluating the distribution of clinical trials around the world, and for providing information for future policy on health R&D.

MPAA, US Blind Federation Urge Narrow Focus In WIPO Treaty For Blind

The US film industry and advocates for the blind joined forces today to urge World Intellectual Property Organization negotiators to keep treaty talks focussed on the core issue of making more books available to the blind and visually impaired. The joint statement appeared to be aimed at reining in stakeholders on both sides of the international debate.

World Health Assembly: IP Considerations Play Key Role In Final Outcomes

Wrapping up one day early, the 66th World Health Assembly adopted a range of public health resolutions and decisions, some with key intellectual property implications, including a decision to convene a technical meeting on new public health R&D projects, a compromise on advancing the poor quality medicines mechanism, and resolutions on both neglected tropical diseases and noncommunicable diseases. Importantly, the novel coronavirus situation drew attention to WHO’s progress in pandemic influenza preparedness.